Steps for Getting CE Marking

The top medical device consultants have relevant industry experience have relevant experience within the industry, knowledge of the right regulatory frameworks, and proven experience working on similar projects. Regardless of whether you’re trying to develop a regulatory strategy, prepare for submission or respond to the FDA, working with a consultant who’s succeeded in similar situations can increase your chances of a favorable outcome. IZiel implements an Outcome-Based Delivery Model to provide a complete solution from developing engineering documentation to receiving USFDA Approvals & establishment registrations thereafter. Our teams from USA & India collaborate to develop a Cost-Effective Model to complete USFDA Approvals for customers in USA, Europe and Asia. Upon completion of Engineering & QMS Documentation , the regulatory team of IZiel conducts the predicate device search, comparative analysis and ensure all the necessary standards are complied with. Thereafter, ...

  Manufacturers are expected to follow the quality system requirements described in FDA 21 CFR part 820 This document guides to govern the design, manufacture, packaging, labelling, storage, installation, and servicing of medical devices intended for human use. The requirements in 21 CFR Part 820 are meant to ensure the safety and efficacy of medical devices sold in the US marketplace. FDA conducts regular inspections of medical device manufacturers to ensure compliance with these regulations. The inspection process, known as the Quality System Inspection Technique (QSIT), evaluates a company’s internal quality processes to determine whether they are in alignment with or in violation of these regulatory requirements. If any violations are discovered, the inspecting agent from FDA will issue in the form of 483 Inspectional Observations, Warning Letters what is applicable   Here are the most common mistakes companies run into with FDA 21 CFR Part 820: 1.  ...

  Manufacturers are expected to follow the quality system requirements described in FDA 21 CFR part 820 This document guides to govern the design, manufacture, packaging, labelling, storage, installation, and servicing of medical devices intended for human use. The requirements in 21 CFR Part 820 are meant to ensure the safety and efficacy of medical devices sold in the US marketplace. FDA conducts regular inspections of medical device manufacturers to ensure compliance with these regulations. The inspection process, known as the Quality System Inspection Technique (QSIT), evaluates a company’s internal quality processes to determine whether they are in alignment with or in violation of these regulatory requirements. If any violations are discovered, the inspecting agent from FDA will issue in the form of 483 Inspectional Observations, Warning Letters what is applicable   Here are the most common mistakes companies run into with FDA 21 CFR Part 820: 1. ...

  Medical device manufacturers receive observations ( Form 483Compliance ) and / or warning letters on completion of USFDA Audit. The document outlines any violations of Good Manufacturing Practices (GMP’s) such as the facility, equipment, processes, controls, products, employee practices or records. Companies require substantial number of unplanned resources, budgets & at the worst are declined an opportunity to sell, shutting down facilities and even prosecution of responsible individuals until the observations are cleared. Companies may also undertake product remediation to resolve issues that they are aware of in their product design and development process. The 6 biggest ways an experienced compliance and remediation consulting firm can help those recovering from a Warning Letter ( Form483 Compliance ) or FDA Warning Letter ·          Objective, un-biased perspectives  ·          ...

DMF (Drug Master file) word is common to all in pharmaceutical field. This phenomena of DMF is origin of US FDA. DMF’s are submissions to US FDA which contains, confidential detailed information about facilities, processes, material used in manufacturing, processing, packaging and storing of human drug products. Advantage of DMF process is, Allow parties to use as reference material without disclosing confidential material content. They are not required by statue organization FDA neither approves or disapproves, FDA uses as review material in the application submissions of NDA’s, ANDA’s, IND’s, and BLAs. DMF is systematic structured document and its structure is guide for people who prepares and submits the same. Various information is available of web pages for, List of DMF’s, Types of DMFs, Submission resources, Templates and related information. US FDA is also preparing FAQ also on DMF. Contact email is dmfquestion@fds.hhs.gov Physical media submission is only accepted if volume is...